Alto Neuroscience Inc - Novel Transdermal Formulation Delivered Significantly Greater Drug Exposure, Fewer Adverse Events Typically Associated With Pde4 Inhibitors
Alto Neuroscience Inc-新型透皮制剂显著增加了药物暴露量,减少了通常与Pde4抑制剂相关的不良事件
Alto Neuroscience Inc - Novel Transdermal Formulation Delivered Significantly Greater Drug Exposure, Fewer Adverse Events Typically Associated With Pde4 Inhibitors
Alto Neuroscience Inc-新型透皮制剂显著增加了药物暴露量,减少了通常与Pde4抑制剂相关的不良事件
使用浏览器的分享功能,分享给你的好友吧